Updates & Member Profiles

The Canadian Nuclear Isotope Council (CNIC) team recently had the opportunity to tour the Brain Imaging Centre at The Royal, our newest Health Partner, and visit their colleagues at the University of Ottawa Heart Institute’s Radiochemistry Laboratory to learn how the organizations have partnered to support brain and cardiac health research. Our visit to The

The CNIC team recently visited its member, AtomVie Global Radiopharma’s (AtomVie’s) new Hamilton facility to get a closer look at the company’s next phase of growth. AtomVie is a global leading radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), which emerged as a spinout of the Centre for Probe Development and Commercialization (CPDC), a McMaster University-founded

On January 12th, the CNIC team had the pleasure of touring the facilities of one of our valued member organizations, Isologic Innovative Radiopharmaceuticals (Isologic), in Burlington, Ontario, for an in-depth look at their radiotracer production processes. Onsite, Frank Maiorino, VP of Commercial and Carlos Fachada, Director of Operations, guided us through their production rooms and

On March 10th, the CNIC team had the distinct pleasure of visiting one of our valued member organizations, Pacer Air Freight, at their facility in Mississauga, Ontario. Pacer Air Freight is a transportation logistics company with over 30 years of experience working with clients to deliver irreplaceable shipments around the world. What began as a

On December 12th and 13th, the Canadian Nuclear Isotope Council (CNIC) was proud to partner with the Canadian Medical Isotope Ecosystem (CMIE) to host the first annual Symposium on Medical Isotopes in Vancouver, BC. As part of the programming of the symposium, attendees, including the CNIC team, were pleased to be invited to visit TRIUMF’s

The Canadian Nuclear Isotope Council (CNIC) team had the pleasure of visiting Western University, in London, Ontario, to meet with leaders from across the University and local partner hospitals to learn about the innovative work on the production and use of medical isotopes in London. Our visit began at the Verspeeten Family Cancer Centre at